Distribution of estimated GSTP1 haplotypes in 64 case subjects and 64 successfully treated matched control subjects with acute lymphoblastic leukemia from ALL-BFM trials 86 and 90
| . | No. of Subjects and Prevalence (%) . | |
|---|---|---|
| Cases . | Controls . | |
| GSTP1*A/GSTP1*A | 32 (50.0) | 31 (48.4) |
| GSTP1*A/GSTP1*B | 19 (29.7) | 13 (20.3) |
| GSTP1*A/GSTP1*C | 8 (12.5) | 10 (15.6) |
| GSTP1*B/GSTP1*B | 2 (3.1) | 5 (7.8) |
| GSTP1*B/GSTP1*C | 2 (3.1) | 5 (7.8) |
| GSTP1*C/GSTP1*D | 1 (1.6) | — |
| . | No. of Subjects and Prevalence (%) . | |
|---|---|---|
| Cases . | Controls . | |
| GSTP1*A/GSTP1*A | 32 (50.0) | 31 (48.4) |
| GSTP1*A/GSTP1*B | 19 (29.7) | 13 (20.3) |
| GSTP1*A/GSTP1*C | 8 (12.5) | 10 (15.6) |
| GSTP1*B/GSTP1*B | 2 (3.1) | 5 (7.8) |
| GSTP1*B/GSTP1*C | 2 (3.1) | 5 (7.8) |
| GSTP1*C/GSTP1*D | 1 (1.6) | — |
See “Results” for explanation of haplotypes.